rs12918952

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016373.4(WWOX):​c.535G>A​(p.Ala179Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.533 in 1,613,106 control chromosomes in the GnomAD database, including 246,241 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A179S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.44 ( 17197 hom., cov: 32)
Exomes 𝑓: 0.54 ( 229044 hom. )

Consequence

WWOX
NM_016373.4 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 7.64

Publications

44 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012559593).
BP6
Variant 16-78386878-G-A is Benign according to our data. Variant chr16-78386878-G-A is described in ClinVar as Benign. ClinVar VariationId is 260740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.593 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WWOXNM_016373.4 linkc.535G>A p.Ala179Thr missense_variant Exon 6 of 9 ENST00000566780.6 NP_057457.1 Q9NZC7-1A0A411HBC7
WWOXNM_001291997.2 linkc.196G>A p.Ala66Thr missense_variant Exon 5 of 8 NP_001278926.1 Q9NZC7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WWOXENST00000566780.6 linkc.535G>A p.Ala179Thr missense_variant Exon 6 of 9 1 NM_016373.4 ENSP00000457230.1 Q9NZC7-1

Frequencies

GnomAD3 genomes
AF:
0.437
AC:
66433
AN:
151856
Hom.:
17201
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.650
Gnomad AMR
AF:
0.425
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.0737
Gnomad SAS
AF:
0.256
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.598
Gnomad OTH
AF:
0.456
GnomAD2 exomes
AF:
0.451
AC:
112445
AN:
249274
AF XY:
0.457
show subpopulations
Gnomad AFR exome
AF:
0.185
Gnomad AMR exome
AF:
0.361
Gnomad ASJ exome
AF:
0.491
Gnomad EAS exome
AF:
0.0622
Gnomad FIN exome
AF:
0.584
Gnomad NFE exome
AF:
0.595
Gnomad OTH exome
AF:
0.502
GnomAD4 exome
AF:
0.543
AC:
793001
AN:
1461132
Hom.:
229044
Cov.:
43
AF XY:
0.537
AC XY:
390311
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.175
AC:
5873
AN:
33472
American (AMR)
AF:
0.368
AC:
16455
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.486
AC:
12699
AN:
26130
East Asian (EAS)
AF:
0.0659
AC:
2618
AN:
39698
South Asian (SAS)
AF:
0.275
AC:
23724
AN:
86242
European-Finnish (FIN)
AF:
0.585
AC:
31229
AN:
53390
Middle Eastern (MID)
AF:
0.471
AC:
2718
AN:
5768
European-Non Finnish (NFE)
AF:
0.601
AC:
667681
AN:
1111346
Other (OTH)
AF:
0.497
AC:
30004
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
17378
34757
52135
69514
86892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17648
35296
52944
70592
88240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.437
AC:
66430
AN:
151974
Hom.:
17197
Cov.:
32
AF XY:
0.432
AC XY:
32071
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.197
AC:
8181
AN:
41446
American (AMR)
AF:
0.424
AC:
6480
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1743
AN:
3468
East Asian (EAS)
AF:
0.0740
AC:
383
AN:
5174
South Asian (SAS)
AF:
0.257
AC:
1232
AN:
4796
European-Finnish (FIN)
AF:
0.578
AC:
6091
AN:
10530
Middle Eastern (MID)
AF:
0.517
AC:
151
AN:
292
European-Non Finnish (NFE)
AF:
0.598
AC:
40616
AN:
67970
Other (OTH)
AF:
0.455
AC:
960
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1667
3335
5002
6670
8337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.533
Hom.:
87017
Bravo
AF:
0.417
TwinsUK
AF:
0.596
AC:
2211
ALSPAC
AF:
0.602
AC:
2321
ESP6500AA
AF:
0.195
AC:
757
ESP6500EA
AF:
0.583
AC:
4823
ExAC
AF:
0.450
AC:
54428
Asia WGS
AF:
0.170
AC:
592
AN:
3478
EpiCase
AF:
0.594
EpiControl
AF:
0.595

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 69% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 64. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive spinocerebellar ataxia 12;C3463992:Developmental and epileptic encephalopathy, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Malignant tumor of esophagus;C3280452:Autosomal recessive spinocerebellar ataxia 12;C4015519:Developmental and epileptic encephalopathy, 28 Benign:1
Nov 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 1 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 28 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive spinocerebellar ataxia 12 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;.
Eigen
Benign
0.14
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.72
T;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.56
N;N
PhyloP100
7.6
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.99
N;N
REVEL
Uncertain
0.43
Sift
Benign
0.53
T;T
Sift4G
Benign
0.21
T;T
Polyphen
0.098
B;.
Vest4
0.49
ClinPred
0.011
T
GERP RS
5.5
Varity_R
0.40
gMVP
0.62
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11545029; hg19: chr16-78420775; COSMIC: COSV68353086; API